Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Argus Health
UBS
Merck
Deloitte
McKesson
Cerilliant
Fish and Richardson
McKinsey

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018153

« Back to Dashboard

NDA 018153 describes BECLOVENT, which is a drug marketed by Glaxosmithkline and is included in one NDA. Additional details are available on the BECLOVENT profile page.

The generic ingredient in BECLOVENT is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
Summary for 018153
Tradename:BECLOVENT
Applicant:Glaxosmithkline
Ingredient:beclomethasone dipropionate
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrength0.042MG/INH
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 018153

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline BECLOVENT beclomethasone dipropionate AEROSOL, METERED;INHALATION 018153-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Glaxosmithkline BECLOVENT beclomethasone dipropionate AEROSOL, METERED;INHALATION 018153-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKinsey
Argus Health
Fuji
Chinese Patent Office
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.